Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of Macrocyclic Pyrimidines as MerTK‐Specific Inhibitors
Andrew L. McIver, Weihe Zhang, Qingyang Liu, et al.
ChemMedChem (2016) Vol. 12, Iss. 3, pp. 207-213
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
K. Myers, Sarah R. Amend, Kenneth J. Pienta
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 334
Macrocycles and macrocyclization in anticancer drug discovery: Important pieces of the puzzle
Chao Zhang, Fenfen Liu, You‐Ming Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116234-116234
Closed Access | Times Cited: 20
MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system
Justus M. Huelse, Diana Fridlyand, Shelton Earp, et al.
Pharmacology & Therapeutics (2020) Vol. 213, pp. 107577-107577
Open Access | Times Cited: 71
Synthetic Opportunities and Challenges for Macrocyclic Kinase Inhibitors
Jennifer Alisa Amrhein, Stefan Knapp, Thomas Hanke
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 7991-8009
Closed Access | Times Cited: 66
Spectroscopic and quantum computational study on naproxen sodium
Rinnu Sara Saji, Johanan Christian Prasana, S. Muthu, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2019) Vol. 226, pp. 117614-117614
Closed Access | Times Cited: 75
MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation
Chihiro Nishi, Yuichi Yanagihashi, Katsumori Segawa, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 18, pp. 7221-7230
Open Access | Times Cited: 56
Discovery of Novel Macrocyclic MERTK/AXL Dual Inhibitors
Deyu Kong, Qiang Tian, Zhilong Chen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5866-5882
Closed Access | Times Cited: 5
Exploiting Structural Variability in the Kinase Back-Pocket to Modulate Polypharmacology of Tam Inhibitors
Megan D. Hopkins, Dehui� Zhang, Zhilong Chen, et al.
(2025)
Closed Access
UNC9426, a Potent and Orally Bioavailable TYRO3-Specific Inhibitor
Deyu Kong, Xiangbo Yang, Samantha Judd, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Exploiting structural variability in the kinase back-pocket to modulate polypharmacology of TAM inhibitors
Megan D. Hopkins, Dehui� Zhang, Zhilong Chen, et al.
European Journal of Medicinal Chemistry (2025), pp. 117561-117561
Closed Access
Design and Evaluation of Potent EGFR Inhibitors through the Incorporation of Macrocyclic Polyamine Moieties into the 4-Anilinoquinazoline Scaffold
Yilan Ju, Jintao Wu, Xi Yuan, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 24, pp. 11372-11383
Closed Access | Times Cited: 30
Rigid Scaffolds Are Promising for Designing Macrocyclic Kinase Inhibitors
Zheng Zhao, Philip E. Bourne
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 8, pp. 1182-1191
Open Access | Times Cited: 8
The small‐molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis
Brian R. Branchford, Timothy J. Stalker, Luke Law, et al.
Journal of Thrombosis and Haemostasis (2017) Vol. 16, Iss. 2, pp. 352-363
Open Access | Times Cited: 27
Highly Selective MERTK Inhibitors Achieved by a Single Methyl Group
Jichen Zhao, Dehui� Zhang, Weihe Zhang, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 22, pp. 10242-10254
Closed Access | Times Cited: 25
Current Trends in Macrocyclic Drug Discovery and beyond -Ro5
Sulejman Alihodžić, Mirjana Bukvić, Ivaylo Elenkov, et al.
Progress in medicinal chemistry (2018), pp. 113-233
Closed Access | Times Cited: 24
BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity
Seung-Hyun Bae, Jung‐Hoon Kim, Tae Hyun Park, et al.
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 9, pp. 1450-1460
Open Access | Times Cited: 11
Discovery of A-910, a Highly Potent and Orally Bioavailable Dual MerTK/Axl-Selective Tyrosine Kinase Inhibitor
Yi‐Yun Yu, Miyeon Jang, Julie M. Miyashiro, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 19, pp. 17000-17032
Closed Access | Times Cited: 2
Two-Front War on Cancer—Targeting TAM Receptors in Solid Tumour Therapy
Agata Mikołajczyk, Filip Mituła, Delfina Popiel, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2488-2488
Open Access | Times Cited: 10
UNC5293, a potent, orally available and highly MERTK-selective inhibitor
Hongchao Zheng, Jichen Zhao, Bing Li, et al.
European Journal of Medicinal Chemistry (2021) Vol. 220, pp. 113534-113534
Closed Access | Times Cited: 11
Research Progress of Axl Inhibitors
Zhigang Sun, Jianhua Liu, Jinmai Zhang, et al.
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 15, pp. 1338-1349
Closed Access | Times Cited: 12
Synthesis and Characterization of a Click-Assembled 18-Atom Macrocycle That Displays Selective AXL Kinase Inhibitory Activity
Olga Cruz‐López, Carolin Temps, Beatrice Longo, et al.
ACS Omega (2019) Vol. 4, Iss. 25, pp. 21620-21626
Open Access | Times Cited: 9
Diagnostic Value of Soluble Form of Mer Tyrosine Kinase (sMerTK) in Tuberculous Pleural Effusion and Malignant Pleural Effusion
Han Liu, Shuai Wang, Zhenzhen Zhang, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-7
Open Access | Times Cited: 8
Crystal Structure of the Kinase Domain of MerTK in Complex with AZD7762 Provides Clues for Structure-Based Drug Development
Tae Hyun Park, Seung-Hyun Bae, Seoung Min Bong, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 7878-7878
Open Access | Times Cited: 5
Macrocyclic effect on inhibitory activity: a modeling study on MerTK inhibitors
Swapnil P. Bhujbal, Seketoulie Keretsu, Pavithra K. Balasubramanian, et al.
Medicinal Chemistry Research (2019) Vol. 28, Iss. 11, pp. 1923-1938
Closed Access | Times Cited: 4
Promiscuity and selectivity of small-molecule inhibitors across TAM receptor tyrosine kinases in pediatric leukemia
Mao-Hua Liu, Shibing Chen, Juan Yu, et al.
Journal of Molecular Graphics and Modelling (2017) Vol. 75, pp. 125-131
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top